AI and Biotechnology Converge to Transform Life Sciences and Biodata Analysis
The convergence of AI and biotechnology is creating a powerful synergy, enabling the analysis of biological data at unprecedented scales. This development is transforming the life sciences industry by allowing researchers to treat biology as a language that can be read, interpreted, and predicted. AI is being used to identify biological markers of disease, group patients more effectively, and design smarter clinical trials. Companies like Pangea Biomed and Algocell are leveraging AI to gain insights from pathology slides and model cell behavior, respectively. This approach is helping researchers make better decisions earlier, saving time, cost, and effort. 
